Skip to content

CorMedix CRMD Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
ITG
Integer HoldingsITGR
IAR
Integra LifeSciencesIART
Emergent Biosolutions logo
Emergent BiosolutionsEBS
ICU Medical logo
ICU MedicalICUI
TFX
TeleflexTFX

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's accrued liabilities, current?
CorMedix (CRMD) reported accrued liabilities, current of $112.77M in Q1 2026.
How has CorMedix's accrued liabilities, current changed year-over-year?
CorMedix's accrued liabilities, current increased by 249.3% year-over-year, from $32.28M to $112.77M.
What is the long-term trend for CorMedix's accrued liabilities, current?
Over 5 years (2020 to 2025), CorMedix's accrued liabilities, current has grown at a 123.6% compound annual growth rate (CAGR), from $2.92M to $163.37M.